Changes in erythropoiesis in hereditary hemochromatosis are not mediated by HFE expression in nucleated red cells

Haematologica

Volumn 90, Issue 2, 2005, Pages 180-187

  Feeney, Graham P ^a   Carter, Kymberley ^a   Masters, Gillian S ^a   Jackson, Helen A ^a   Cavil, Ivor ^a   Worwood, Mark ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Erythropoiesis; Hemochromatosis; HFE; Iron; Transferrin receptor

Indexed keywords

HFE PROTEIN; MESSENGER RNA; TRANSFERRIN RECEPTOR;

ARTICLE; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IRON METABOLISM; IRON TRANSPORT; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RETICULOCYTE COUNT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; CELL LINE, TUMOR; CELL NUCLEUS; ERYTHROCYTES; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MACROPHAGES; MALE; MEMBRANE PROTEINS; MONOCYTES; RECEPTORS, TRANSFERRIN;

EID: 14344249634     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bothwell TH Macphail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 1998;35:55-71.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-Iike gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
3. Worwood M. A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium. Gut 1997;41:841-4.
4. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10 500 blood donors. B J Haematol 2001;114:474-84.
5. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, et al. The hemochromatosis founder mutation in HLA-H disrupts β(2)-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-8.
6. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94:13198-202.
7. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999;96:1579-84.
8. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95: 1472-7.
9. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with β(2)-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997;94:12384-9.
10. Roy CN, Penny DM, Feder JN, Enns CA. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 1999;274:9022-8.
11. Riedel HD, Muckenthaler MU, Gehrke SG, Mohr I, Brennan K, Herrmann T, et al. HFE downregulates iron uptake from transferrin and induces iron - regulatory protein activity in stably transfected cells. Blood 1999;94:3915-21.
12. Feeney GP, Worwood M. The effects of wild-type and mutant HFE expression upon cellular iron uptake in transfected human embryonic kidney cells. Biochim Biophys Acta-Mol Cell Res 2001;1538:242-51.
13. Bastin JM, Jones M, O'Callaghan CA, Schimanski L, Mason DY, Townsend ARM. Küpffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis. Br J Haematol 1998;103:931-41.
14. Santos M, Schilham MW, Rademakers LHPM, Marx JJM, Desousa M, Clevers H. Defective iron homeostasis in β2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 1996;184:1975-85.
15. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang JX, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95: 2492-7.
16. Montosi G, Paglia P, Garuti C, Guzman CA, Bastin JM, Colombo MP, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000; 96:1125-9.
17. Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 2002;359:786-90.
18. Barton JC, Bertoli LF, Rothenberg BE. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content. J Lab Clin Med 2000;135:96-104.
19. Finch CA, Brown KD, Cook JD, Eschbach JW, Harker DD, Funk DD, et al. Ferrokinetics in man. Medicine 1970; 49:17.
20. Cavill I, Ricketts C. Haemochromatosis: iron kinetics and erythropoiesis. Blood 1999;94:414a[abstract].
21. Cavill I, Worwood M, Jacobs A. Internal regulation of iron absorption. Nature 1975;256:328-9.
22. Worwood M. Iron deficiency anaemia and iron overload. In: Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis Practical Haematology. London: Churchill Livingstone; 2001. p. 115-28.
23. Masters GS, Bumett AK. Serum-free culture of human megakaryocyte progenitors. Clin Lab Haematol 1997;19: 61-5.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid ganidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162:156-9.
25. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102: 783-8.
26. Muckenthaler M, Roy CN, Custodio AO, Minana B, deGraaf J, Montross LK, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Gen 2003;34: 102-7.
27. Yamaji S, Sharp P, Ramesh B, Srai SK. Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 2004;104:2178-80.
28. Chitambar CR, Wereley JP. Expression of the hemochromatosis (HFE) gene modulates the cellular uptake of Ga-67. J Nucl Med 2003;44:943-6.
29. Parkkila S, Parkkila AK, Waheed A, Britton RS, Zhou XY, Fleming RE, et al. Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. Haematologica 2000;85: 340-5.
30. Parmley RT, Hajdu I, Denys FR. Ultrastructural localization of the transferrin receptor and transferrin on marrow cell-surfaces. Br J Haematol 1983;54: 633-41.
31. Policard A, Bessis M. A method of incorporation of macromolecules into the cells as determined by the electron microscope: rhopheocytosis. C R Hebd Seances Acad Sci 1958;246:3194-7.
32. Meyron-Holtz EG, Vaisman B, Cabantchik ZI, Fibach E, Rouault TA, Hershko C, et al. Regulation of intracellular iron metabolism in human erythroid precursors by internalized extracellular ferritin. Blood 1999;94: 3205-11.
33. De Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJM. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000;30:248-51.
34. Batey RG, Lai CF, Shamir S, Sherlock S. Non-transferrin bound serum iron in idiopathic haemochromatosis. Digest Dise Sci 1980;25:340-6.
35. Aruoma OI, Bomford A, Polson RJ, Halliwell B. Non-transferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 1988;72:1416-9.
36. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989;264:4417-22.
37. deValk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJM. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000;30: 248-51.
38. Browne P, Shalev O, Hebbel RP. The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radical Biol Med 1998;24: 1040-8.
39. Galleano M, Puntarulo S. Role of antioxidants on the erythrocytes resistance to lipid peroxidation after acute iron overload in rats. BBA-Mol Basis Dis 1995;1271:321-6.
40. Akoev VR, Shcherbinina SP, Matveev AV, Tarakhovskii YS, Deev AA, Shnyrov VL. Structural transitions in erythrocyte membranes in hereditary hemochromatosis. Bul Exp Biol Med 1997;123:242-7.